Search - tctmd.com

Displaying 41 - 60 of 634

Sort: Relevancy | Date

News Daily News

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist

Todd Neale

January 15, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Some Guidance for Managing Patients With AS and CAD: Review

Yael L. Maxwell

December 24, 2024

News Daily News

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Yael L. Maxwell

December 13, 2024

Podcast TCTMD Talking Points

Inflammatory Risk in Statin-Treated Patients

December 11, 2024

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News AHA 2024

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

Caitlin E. Cox

November 21, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

PRO: Time is Now: Targeting Acute Inflammation and Residual Inflammatory Risk

Presenter: Vijay Kunadian

October 29, 2024

Presentation TCT 2024

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Presenter: Ryo Hikida

October 29, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

Modern GDMT for HFrEF: Great but Significant Residual Risks Remain

Presenter: Javed Butler

October 28, 2024

Advertisement

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Some Guidance for Managing Patients With AS and CAD: Review

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Inflammatory Risk in Statin-Treated Patients

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

PRO: Time is Now: Targeting Acute Inflammation and Residual Inflammatory Risk

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Modern GDMT for HFrEF: Great but Significant Residual Risks Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content